Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of clinical-radiological and radiomics features for predicting pulmonary nodule malignancy in a multicenter study of mixed clinical and surveillance populations.

European radiology·2026
Same author

PIK3CB Inhibitor GSK2636771 in Cancers With <i>PTEN</i> Mutation/Deletion or Loss of PTEN Protein Expression: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols N and P.

JCO precision oncology·2025
Same author

Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics.

Molecular oncology·2025
Same author

Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing.

Cancer medicine·2025
Same author

Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial.

JAMA oncology·2025

Related Experiment Video

Updated: Apr 1, 2026

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

12.0K

Accessing Genetic Information with Liquid Biopsies.

Xuyu Cai1, Filip Janku2, Qimin Zhan3

  • 1Oncology, Illumina, Inc., 5200 Illumina Way, San Diego, CA 92122, USA.

Trends in Genetics : TIG
|October 10, 2015
PubMed
Summary

Molecular liquid biopsies analyze blood biomarkers like circulating tumor cells and cell-free DNA/RNA for non-invasive disease diagnosis and monitoring. These advanced techniques are crucial for the future of precision medicine.

More Related Videos

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.8K
Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
14:54

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

3.4K

Related Experiment Videos

Last Updated: Apr 1, 2026

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

12.0K
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.8K
Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
14:54

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

3.4K

Area of Science:

  • Biomarkers
  • Molecular Diagnostics
  • Genomics

Background:

  • Advances in analyzing circulating tumor cells, cell-free DNA/RNA, and exosomes have enabled molecular liquid biopsies.
  • Liquid biopsies offer non-invasive access to critical genetic and epigenetic information from blood.

Purpose of the Study:

  • To highlight the potential of molecular liquid biopsies in disease diagnosis and monitoring.
  • To emphasize the role of liquid biopsies in advancing precision medicine.

Main Methods:

  • Analysis of circulating tumor cells.
  • Detection of cell-free DNA/RNA.
  • Exosome characterization.
  • Next-generation sequencing technologies.

Main Results:

  • Molecular liquid biopsies provide insights into somatic mutations, epigenetic changes, and gene expression.
  • This approach facilitates non-invasive genetic profiling for various conditions.

Conclusions:

  • Molecular liquid biopsies are foundational for routine diagnostics.
  • They represent a key component of future precision medicine, aiding in prenatal, neurodegenerative, and cancer applications.